EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Disseminated septic arthritis caused by Ureaplasma urealyticum in an immunocompromised patient with hypogammaglobulinemia after rituximab therapy

Kohei Oguni, Shinnosuke Fukushima, Yuki Otsuka, Yoshiaki Soejima, Marina Kawaguchi, Yosuke Sazumi, Takumi Fujimori, Koji Iio, Noriyuki Umakoshi, Kazuki Yamada, Hideharu Hagiya, Fumio Otsuka

Infection · 2024

DOI: 10.1007/s15010-024-02301-1 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Infection, 2024. Verfasst von Kohei Oguni und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata-cho, Kitaku, Ok…. Hauptthemen laut MEDLINE: Ureaplasma urealyticum, Arthritis, Infectious, Agammaglobulinemia, Ureaplasma Infections. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Okayama University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Ureaplasma urealyticum is a rare pathogen associated with septic arthritis that predominantly affects patients with hypogammaglobulinemia. Bacterial identification of fastidious organisms is challenging because they are undetectable by routine culture testing. To the best of our knowledge, this is the first report of septic arthritis induced by U. urealyticum infection in Japan. Case description We describe the case of a 23-year-old Japanese female with secondary hypogammaglobulinemia (serum immunoglobulin level < 500 mg/dL), identified 8 years after treatment with rituximab. The patient presented with persistent fever and polyarthritis that were unresponsive to ceftriaxone and prednisolone. Contrast-enhanced computed tomography and gallium-67 scintigraphy revealed effusion and inflammation in the left sternoclavicular, hip, wrist, knee, and ankle joints. Although Gram staining and bacterial culture of the drainage fluid from the left hip joint were negative, the condition exhibited characteristics of purulent bacterial infection. The patient underwent empirical treatment with doxycycline, and her symptoms promptly resolved. Subsequent 16S ribosomal RNA (rRNA) gene sequencing of the joint fluid confirmed the presence of U. urealyticum, leading to the diagnosis of septic arthritis . Combination therapy with doxycycline and azithromycin yielded a favorable recovery from the inflammatory status and severe arthritic pain.

Conclusion

This case highlights U. urealyticum as a potential causative agent of disseminated septic arthritis, particularly in patients with hypogammaglobulinaemia. The 16S rRNA gene analysis proved beneficial for identifying pathogens in culture-negative specimens, such as synovial fluid, in suspected bacterial infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ureaplasma urealyticumArthritis, InfectiousAgammaglobulinemiaUreaplasma InfectionsRituximabImmunocompromised HostAnti-Bacterial AgentsHumansFemaleYoung AdultJapanDoxycyclineAzithromycinRNA, Ribosomal, 16S

Stichwörter der Autor:innen

Ureaplasma urealyticum16S rRNA gene sequencingHypogammaglobulinemiaJoint infectionRituximabα-Defensin

Substanzen

RituximabAnti-Bacterial AgentsDoxycyclineAzithromycinRNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Department of General Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata-cho, Kitaku, Okayama, 700-8558, Japan.
  • Department of Infectious Diseases, Okayama University Hospital, Okayama, Japan.
  • Department of Bacteriology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
  • Microbiology Division, Clinical Laboratory, Okayama University Hospital, Okayama, Japan.
  • Department of Radiology, Okayama University Hospital, Okayama, Japan.
  • Department of Medical Materials for Musculoskeletal Reconstruction, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.

Förderung

  • Okayama University

Zitieren

APA

Oguni, K., Fukushima, S., Otsuka, Y., Soejima, Y., Kawaguchi, M., Sazumi, Y., Fujimori, T., Iio, K., Umakoshi, N., Yamada, K., Hagiya, H., & Otsuka, F. (2024). Disseminated septic arthritis caused by Ureaplasma urealyticum in an immunocompromised patient with hypogammaglobulinemia after rituximab therapy. Infection. https://doi.org/10.1007/s15010-024-02301-1

Vancouver

Oguni K, Fukushima S, Otsuka Y, Soejima Y, Kawaguchi M, Sazumi Y, et al. Disseminated septic arthritis caused by Ureaplasma urealyticum in an immunocompromised patient with hypogammaglobulinemia after rituximab therapy. Infection. 2024. doi:10.1007/s15010-024-02301-1

BibTeX
@article{Oguni2024,
  author = {Oguni, Kohei and Fukushima, Shinnosuke and Otsuka, Yuki and Soejima, Yoshiaki and Kawaguchi, Marina and Sazumi, Yosuke and Fujimori, Takumi and Iio, Koji and Umakoshi, Noriyuki and Yamada, Kazuki and Hagiya, Hideharu and Otsuka, Fumio},
  title = {Disseminated septic arthritis caused by Ureaplasma urealyticum in an immunocompromised patient with hypogammaglobulinemia after rituximab therapy},
  journal = {Infection},
  year = {2024},
  doi = {10.1007/s15010-024-02301-1}
}
Kostenlos starten →